Maxim Group analyst Jason McCarthy reiterated a Buy rating on Iterum Therapeutics today and set a price target of $5.00. The company’s shares closed yesterday at $0.67.Elevate Your Investing Strategy:...
Iterum Therapeutics confirms compliance with Nasdaq listing requirements, allowing continued trading of its stock.Quiver AI SummaryIterum Therapeutics plc announced that it has resolved its compliance...
NEW YORK, NY / ACCESSWIRE / October 4, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...
NEW YORK, NY / ACCESSWIRE / October 4, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...
NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...
NEW YORK, NY / ACCESSWIRE / October 4, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...
NEW YORK, NY / ACCESSWIRE / October 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...
NEW YORK, NY / ACCESSWIRE / October 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....